European Academy of Dermatology and Venereology

Maintenance tacrolimus for eczema boosts quality of life

Posted on: 15/12/2014 - 14:13

AMSTERDAM – Twice-weekly proactive maintenance therapy with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis resulted in dramatic improvement in self-reported quality of...

Field of Interest: Dermatology
Type: News Item

Novel oral prophylaxis tames hereditary angioedema

Posted on: 03/12/2014 - 18:13

AMSTERDAM – A targeted oral medication for the prevention of potentially life-threatening episodes of hereditary angioedema produced a clinically meaningful reduction in attack frequency in a...

Field of Interest: Dermatology
Type: News Item

Dupilumab advances for severe atopic dermatitis

Posted on: 18/11/2014 - 19:45

AMSTERDAM – The novel biologic agent dupilumab showed strong dose-dependent efficacy in adults with moderate to severe atopic dermatitis not adequately controlled with topical medications in a...

Field of Interest: Dermatology
Type: News Item

Low-risk actinic keratosis? No such thing

Posted on: 13/11/2014 - 19:13

AMSTERDAM – The majority of cutaneous infiltrating squamous cell carcinomas arise via direct transformation of grade 1 actinic keratoses – that is, differentiated dysplasia of the basal one-third of...

Field of Interest: Dermatology
Type: News Item

Oral curcumin shown effective in psoriasis

Posted on: 10/11/2014 - 15:35

AMSTERDAM – Oral curcumin proved safe and effective as adjunctive therapy in patients on topical corticosteroids for mild to moderate psoriasis vulgaris in a 12-week, randomized, placebo-controlled...

Field of Interest: Dermatology
Type: News Item

Rosacea’s comorbidities are more than skin deep

Posted on: 16/10/2014 - 17:32

AMSTERDAM – Rosacea is associated with increased risk of a range of chronic systemic diseases, including allergies and urogential disorders, a case-control study showed. The common denominator...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More